NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹3,311 Cr | ₹2,863 Cr | ₹2,657 Cr | ₹2,622 Cr | ₹2,447 Cr |
What is the latest Total Non-Current Assets ratio of NATCO PHARMA ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹3,311 Cr |
| Mar2024 | ₹2,863 Cr |
| Mar2023 | ₹2,657 Cr |
| Mar2022 | ₹2,622 Cr |
| Mar2021 | ₹2,447 Cr |
How is Total Non-Current Assets of NATCO PHARMA Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,311 Cr | 15.62 | |
| Mar2024 | ₹2,863 Cr | 7.76 | |
| Mar2023 | ₹2,657 Cr | 1.32 | |
| Mar2022 | ₹2,622 Cr | 7.16 | |
| Mar2021 | ₹2,447 Cr | - | |
Compare Total Non-Current Assets of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹17,129.1 Cr | 1.3% | 16.9% | 20.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 1.3% |
16.9% |
20.2% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses